CLINICAL SAFETY AND DRUG INTERACTIONS WITH 8-AMINOQUINOLINES

H. Myint; Colin Ohrt; Aruna Sampath; LA Walker; Sir Nicholas White; Alan J. Magill

Article1991

Interleukin-8 and malaria

Jon S. Friedland, M. Ho, D Remick, D Bunnag, Sir Nicholas White, GE Griffin

Cytokine

Article1977

ChemInform Abstract: CHEMICAL CONSEQUENCES OF ORBITAL INTERACTIONS. 8. THE IMPORTANCE OF THE COUNTERION. THE RELATIVE ENERGIES OF HOMOCUBYL CATIONS AND ION PAIRS

William L. Jorgensen

Chemischer Informationsdienst

Chapter in a book2021

Interactions of Peptides with Lipid Bilayers

Stephen H. White, Gunnar Von Heijne, Donald M. Engelman

Article2012

POOLED ANALYSIS OF LONG-TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM

Jorge Belardi, Alan C. Yeung, Martin B. Leon, Patrick W. Serruys, Ian T. Meredith, Stephan Windecker, Sigmund Silber, Franz‐Josef Neumann, Petr Widimský, Shigeru Saito, Joseph M. Massaro, Laura Mauri

Journal of the American College of Cardiology

Article2013

POOLED ANALYSIS OF LONG–TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM

Ganesh Manoharan, Franz‐Josef Neumann, Stephan Windecker, Martin B. Leon, Ian T. Meredith, Shigeru Saito, Patrick W. Serruys, Sigmund Silber, Alan C. Yeung, Jorge Belardi, Petr Widimský, Laura Mauri

Journal of the American College of Cardiology

CLINICAL SAFETY AND DRUG INTERACTIONS WITH 8-AMINOQUINOLINES

Abstract

Discussion(0)

Related publications

Interleukin-8 and malaria

ChemInform Abstract: CHEMICAL CONSEQUENCES OF ORBITAL INTERACTIONS. 8. THE IMPORTANCE OF THE COUNTERION. THE RELATIVE ENERGIES OF HOMOCUBYL CATIONS AND ION PAIRS

Interactions of Peptides with Lipid Bilayers

POOLED ANALYSIS OF LONG-TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM

POOLED ANALYSIS OF LONG–TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM